Global Tysabri Market Insights, Forecast to 2025

Published On: Jun 2019

Format: PDF

Publisher: QY Research

Pages: 115

Report ID: 19086

Tysabri (natalizumab) is a monoclonal antibody used in to treat relapsing forms of multiple sclerosis. Tysabri is also used to treat moderate to severe Crohn's disease in adults. Tysabri is usually given after other Crohn's disease medications have been tried without successful treatment of this condition.
The global Tysabri market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Tysabri market based on company, product type, end user and key regions.

This report studies the global market size of Tysabri in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Tysabri in these regions.
This research report categorizes the global Tysabri market by top players/brands, region, type and end user. This report also studies the global Tysabri market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Biogen

Market size by Product
Multiple Sclerosis
Crohn's Disease
Market size by End User
Hospital
Drugs Stores

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Tysabri market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Tysabri market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Tysabri companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Tysabri submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Tysabri are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Tysabri market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Study Coverage
1.1 Tysabri Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Tysabri Market Size Growth Rate by Product
1.4.2 Multiple Sclerosis
1.4.3 Crohn's Disease
1.5 Market by End User
1.5.1 Global Tysabri Market Size Growth Rate by End User
1.5.2 Hospital
1.5.3 Drugs Stores
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Tysabri Market Size
2.1.1 Global Tysabri Revenue 2014-2025
2.1.2 Global Tysabri Sales 2014-2025
2.2 Tysabri Growth Rate by Regions
2.2.1 Global Tysabri Sales by Regions
2.2.2 Global Tysabri Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Tysabri Sales by Manufacturers
3.1.1 Tysabri Sales by Manufacturers
3.1.2 Tysabri Sales Market Share by Manufacturers
3.1.3 Global Tysabri Market Concentration Ratio (CR5 and HHI)
3.2 Tysabri Revenue by Manufacturers
3.2.1 Tysabri Revenue by Manufacturers (2014-2019)
3.2.2 Tysabri Revenue Share by Manufacturers (2014-2019)
3.3 Tysabri Price by Manufacturers
3.4 Tysabri Manufacturing Base Distribution, Product Types
3.4.1 Tysabri Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Tysabri Product Type
3.4.3 Date of International Manufacturers Enter into Tysabri Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global Tysabri Sales by Product
4.2 Global Tysabri Revenue by Product
4.3 Tysabri Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global Tysabri Breakdown Data by End User

6 North America
6.1 North America Tysabri by Countries
6.1.1 North America Tysabri Sales by Countries
6.1.2 North America Tysabri Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Tysabri by Product
6.3 North America Tysabri by End User

7 Europe
7.1 Europe Tysabri by Countries
7.1.1 Europe Tysabri Sales by Countries
7.1.2 Europe Tysabri Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Tysabri by Product
7.3 Europe Tysabri by End User

8 Asia Pacific
8.1 Asia Pacific Tysabri by Countries
8.1.1 Asia Pacific Tysabri Sales by Countries
8.1.2 Asia Pacific Tysabri Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Tysabri by Product
8.3 Asia Pacific Tysabri by End User

9 Central & South America
9.1 Central & South America Tysabri by Countries
9.1.1 Central & South America Tysabri Sales by Countries
9.1.2 Central & South America Tysabri Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Tysabri by Product
9.3 Central & South America Tysabri by End User

10 Middle East and Africa
10.1 Middle East and Africa Tysabri by Countries
10.1.1 Middle East and Africa Tysabri Sales by Countries
10.1.2 Middle East and Africa Tysabri Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Tysabri by Product
10.3 Middle East and Africa Tysabri by End User

11 Company Profiles
11.1 Biogen
11.1.1 Biogen Company Details
11.1.2 Company Business Overview
11.1.3 Biogen Tysabri Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Biogen Tysabri Products Offered
11.1.5 Biogen Recent Development

12 Future Forecast
12.1 Tysabri Market Forecast by Regions
12.1.1 Global Tysabri Sales Forecast by Regions 2019-2025
12.1.2 Global Tysabri Revenue Forecast by Regions 2019-2025
12.2 Tysabri Market Forecast by Product
12.2.1 Global Tysabri Sales Forecast by Product 2019-2025
12.2.2 Global Tysabri Revenue Forecast by Product 2019-2025
12.3 Tysabri Market Forecast by End User
12.4 North America Tysabri Forecast
12.5 Europe Tysabri Forecast
12.6 Asia Pacific Tysabri Forecast
12.7 Central & South America Tysabri Forecast
12.8 Middle East and Africa Tysabri Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Tysabri Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer